Surufatinib Combined With KN046 and AG Regimen Chemotherapy as First-Line Treatment for Unresectable Advanced Pancreatic Cancer
Clinical trial NCT05832892 · UNKNOWN
Trial details
- NCT number
- NCT05832892
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-01
- Primary completion
- 2024-11-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.